Shares of Item 9 Labs Corp. (OTC:INLB – Get Rating) were up 23.5% during trading on Friday . The stock traded as high as $0.21 and last traded at $0.21. Approximately 15,915 shares traded hands during mid-day trading, a decline of 14% from the average daily volume of 18,450 shares. The stock had previously closed at $0.17.
Item 9 Labs Price Performance
The company has a market capitalization of $20.79 million, a P/E ratio of -0.84 and a beta of 0.55. The business's 50-day moving average is $0.26 and its two-hundred day moving average is $0.45. The company has a quick ratio of 0.04, a current ratio of 0.14 and a debt-to-equity ratio of 0.02.
About Item 9 Labs
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.
- Get a free copy of the StockNews.com research report on Item 9 Labs (INLB)
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don't Buy It Just Yet
Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.